Trial Profile
Evaluation of the Effect of Ambrisentan on Digital Microvascular Flow in Patients With Systemic Sclerosis Using Laser Doppler Perfusion Imaging
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jan 2016
Price :
$35
*
At a glance
- Drugs Ambrisentan (Primary)
- Indications Systemic scleroderma
- Focus Therapeutic Use
- 29 Jan 2016 New trial record